Quetiapine Fumarate
NDC 34908-639, quetiapine fumarate, tablet, extended release, from Novast Laboratories, Ltd..
- Product NDC
- 34908-639
- Status
- Listed
- Labeler
- Novast Laboratories, Ltd.
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA208947
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/34908-639 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- QUETIAPINE FUMARATE400 mg/1
Pharmacologic classes
Atypical Antipsychotic [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 34908-639-10 | 34908063910 | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (34908-639-10) |
| 34908-639-30 | 34908063930 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (34908-639-30) |
| 34908-639-60 | 34908063960 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (34908-639-60) |
| 34908-639-90 | 34908063990 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (34908-639-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 34908-639 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/34908-639 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 34908-639. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.